The combination of coffee compounds attenuates early fibrosis-associated hepatocarcinogenesis in mice: involvement of miRNA profile modulation

Detalhes bibliográficos
Autor(a) principal: Romualdo, Guilherme Ribeiro [UNESP]
Data de Publicação: 2020
Outros Autores: Prata, Gabriel Bacil [UNESP], da Silva, Tereza Cristina, Evangelista, Adriane Feijó, Reis, Rui Manuel, Vinken, Mathieu, Moreno, Fernando Salvador, Cogliati, Bruno, Barbisan, Luís Fernando [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1016/j.jnutbio.2020.108479
http://hdl.handle.net/11449/201020
Resumo: Aberrant microRNA expression implicates on hepatocellular carcinoma (HCC) development. Conversely, coffee consumption reduces by ~40% the risk for fibrosis/cirrhosis and HCC, while decaffeinated coffee does not. It is currently unknown whether these protective effects are related to caffeine (CAF), or to its combination with other common and/or highly bioavailable coffee compounds, such as trigonelline (TRI) and chlorogenic acid (CGA). We evaluated whether CAF individually or combined with TRI and/or CGA alleviates fibrosis-associated hepatocarcinogenesis, examining the involvement of miRNA profile modulation. Then, male C3H/HeJ mice were submitted to a diethylnitrosamine/carbon tetrachloride-induced model. Animals received CAF (50 mg/kg), CAF+TRI (50 and 25 mg/kg), CAF+CGA (50 and 25 mg/kg) or CAF+TRI+CGA (50, 25 and 25 mg/kg), intragastrically, 5×/week, for 10 weeks. Only CAF+TRI+CGA combination reduced the incidence, number and proliferation (Ki-67) of hepatocellular preneoplastic foci while enhanced apoptosis (cleaved caspase-3) in adjacent parenchyma. CAF+TRI+CGA treatment also decreased hepatic oxidative stress and enhanced the antioxidant Nrf2 axis. CAF+TRI+CGA had the most pronounced effects on decreasing hepatic pro-inflammatory IL-17 and NFκB, contributing to reduce CD68-positive macrophage number, stellate cell activation, and collagen deposition. In agreement, CAF+TRI+CGA upregulated tumor suppressors miR-144-3p, miR-376a-3p and antifibrotic miR-15b-5p, frequently deregulated in human HCC. CAF+TRI+CGA reduced the hepatic protein levels of pro-proliferative EGFR (miR-144-3p target), antiapoptotic Bcl-2 family members (miR-15b-5p targets), and the number of PCNA (miR-376a-3p target) positive hepatocytes in preneoplastic foci. Our results suggest that the combination of most common and highly bioavailable coffee compounds, rather than CAF individually, attenuates fibrosis-associated hepatocarcinogenesis by modulating miRNA expression profile.
id UNSP_3893e0fd1dd1e058997f1b65766acdae
oai_identifier_str oai:repositorio.unesp.br:11449/201020
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling The combination of coffee compounds attenuates early fibrosis-associated hepatocarcinogenesis in mice: involvement of miRNA profile modulationCaffeineChlorogenic acidHepatocarcinogenesisLiver fibrosismiRNATrigonellineAberrant microRNA expression implicates on hepatocellular carcinoma (HCC) development. Conversely, coffee consumption reduces by ~40% the risk for fibrosis/cirrhosis and HCC, while decaffeinated coffee does not. It is currently unknown whether these protective effects are related to caffeine (CAF), or to its combination with other common and/or highly bioavailable coffee compounds, such as trigonelline (TRI) and chlorogenic acid (CGA). We evaluated whether CAF individually or combined with TRI and/or CGA alleviates fibrosis-associated hepatocarcinogenesis, examining the involvement of miRNA profile modulation. Then, male C3H/HeJ mice were submitted to a diethylnitrosamine/carbon tetrachloride-induced model. Animals received CAF (50 mg/kg), CAF+TRI (50 and 25 mg/kg), CAF+CGA (50 and 25 mg/kg) or CAF+TRI+CGA (50, 25 and 25 mg/kg), intragastrically, 5×/week, for 10 weeks. Only CAF+TRI+CGA combination reduced the incidence, number and proliferation (Ki-67) of hepatocellular preneoplastic foci while enhanced apoptosis (cleaved caspase-3) in adjacent parenchyma. CAF+TRI+CGA treatment also decreased hepatic oxidative stress and enhanced the antioxidant Nrf2 axis. CAF+TRI+CGA had the most pronounced effects on decreasing hepatic pro-inflammatory IL-17 and NFκB, contributing to reduce CD68-positive macrophage number, stellate cell activation, and collagen deposition. In agreement, CAF+TRI+CGA upregulated tumor suppressors miR-144-3p, miR-376a-3p and antifibrotic miR-15b-5p, frequently deregulated in human HCC. CAF+TRI+CGA reduced the hepatic protein levels of pro-proliferative EGFR (miR-144-3p target), antiapoptotic Bcl-2 family members (miR-15b-5p targets), and the number of PCNA (miR-376a-3p target) positive hepatocytes in preneoplastic foci. Our results suggest that the combination of most common and highly bioavailable coffee compounds, rather than CAF individually, attenuates fibrosis-associated hepatocarcinogenesis by modulating miRNA expression profile.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Department of Pathology Botucatu Medical School São Paulo State University (UNESP)Department of Structural and Functional Biology Biosciences Institute São Paulo State University (UNESP)Department of Pathology School of Veterinary Medicine and Animal Science University of São Paulo (USP)Molecular Oncology Research Center Barretos Cancer HospitalDepartment of In Vitro Toxicology and Dermato-Cosmetology Faculty of Medicine and Pharmacy Vrije Universiteit BrusselDepartment of Food and Experimental Nutrition Faculty of Pharmaceutical Sciences University of São Paulo (USP)Life and Health Sciences Research Institute (ICVS) School of Medicine University of Minho3B's - PT Government Associate LaboratoryDepartment of Pathology Botucatu Medical School São Paulo State University (UNESP)Department of Structural and Functional Biology Biosciences Institute São Paulo State University (UNESP)FAPESP: #2016/12015–0FAPESP: #2016/14420–0FAPESP: #2017/16596–0Universidade Estadual Paulista (Unesp)Universidade de São Paulo (USP)Barretos Cancer HospitalVrije Universiteit BrusselUniversity of Minho3B's - PT Government Associate LaboratoryRomualdo, Guilherme Ribeiro [UNESP]Prata, Gabriel Bacil [UNESP]da Silva, Tereza CristinaEvangelista, Adriane FeijóReis, Rui ManuelVinken, MathieuMoreno, Fernando SalvadorCogliati, BrunoBarbisan, Luís Fernando [UNESP]2020-12-12T02:22:06Z2020-12-12T02:22:06Z2020-11-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://dx.doi.org/10.1016/j.jnutbio.2020.108479Journal of Nutritional Biochemistry, v. 85.1873-48470955-2863http://hdl.handle.net/11449/20102010.1016/j.jnutbio.2020.1084792-s2.0-85090426256Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengJournal of Nutritional Biochemistryinfo:eu-repo/semantics/openAccess2024-09-03T13:14:52Zoai:repositorio.unesp.br:11449/201020Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestrepositoriounesp@unesp.bropendoar:29462024-09-03T13:14:52Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv The combination of coffee compounds attenuates early fibrosis-associated hepatocarcinogenesis in mice: involvement of miRNA profile modulation
title The combination of coffee compounds attenuates early fibrosis-associated hepatocarcinogenesis in mice: involvement of miRNA profile modulation
spellingShingle The combination of coffee compounds attenuates early fibrosis-associated hepatocarcinogenesis in mice: involvement of miRNA profile modulation
Romualdo, Guilherme Ribeiro [UNESP]
Caffeine
Chlorogenic acid
Hepatocarcinogenesis
Liver fibrosis
miRNA
Trigonelline
title_short The combination of coffee compounds attenuates early fibrosis-associated hepatocarcinogenesis in mice: involvement of miRNA profile modulation
title_full The combination of coffee compounds attenuates early fibrosis-associated hepatocarcinogenesis in mice: involvement of miRNA profile modulation
title_fullStr The combination of coffee compounds attenuates early fibrosis-associated hepatocarcinogenesis in mice: involvement of miRNA profile modulation
title_full_unstemmed The combination of coffee compounds attenuates early fibrosis-associated hepatocarcinogenesis in mice: involvement of miRNA profile modulation
title_sort The combination of coffee compounds attenuates early fibrosis-associated hepatocarcinogenesis in mice: involvement of miRNA profile modulation
author Romualdo, Guilherme Ribeiro [UNESP]
author_facet Romualdo, Guilherme Ribeiro [UNESP]
Prata, Gabriel Bacil [UNESP]
da Silva, Tereza Cristina
Evangelista, Adriane Feijó
Reis, Rui Manuel
Vinken, Mathieu
Moreno, Fernando Salvador
Cogliati, Bruno
Barbisan, Luís Fernando [UNESP]
author_role author
author2 Prata, Gabriel Bacil [UNESP]
da Silva, Tereza Cristina
Evangelista, Adriane Feijó
Reis, Rui Manuel
Vinken, Mathieu
Moreno, Fernando Salvador
Cogliati, Bruno
Barbisan, Luís Fernando [UNESP]
author2_role author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (Unesp)
Universidade de São Paulo (USP)
Barretos Cancer Hospital
Vrije Universiteit Brussel
University of Minho
3B's - PT Government Associate Laboratory
dc.contributor.author.fl_str_mv Romualdo, Guilherme Ribeiro [UNESP]
Prata, Gabriel Bacil [UNESP]
da Silva, Tereza Cristina
Evangelista, Adriane Feijó
Reis, Rui Manuel
Vinken, Mathieu
Moreno, Fernando Salvador
Cogliati, Bruno
Barbisan, Luís Fernando [UNESP]
dc.subject.por.fl_str_mv Caffeine
Chlorogenic acid
Hepatocarcinogenesis
Liver fibrosis
miRNA
Trigonelline
topic Caffeine
Chlorogenic acid
Hepatocarcinogenesis
Liver fibrosis
miRNA
Trigonelline
description Aberrant microRNA expression implicates on hepatocellular carcinoma (HCC) development. Conversely, coffee consumption reduces by ~40% the risk for fibrosis/cirrhosis and HCC, while decaffeinated coffee does not. It is currently unknown whether these protective effects are related to caffeine (CAF), or to its combination with other common and/or highly bioavailable coffee compounds, such as trigonelline (TRI) and chlorogenic acid (CGA). We evaluated whether CAF individually or combined with TRI and/or CGA alleviates fibrosis-associated hepatocarcinogenesis, examining the involvement of miRNA profile modulation. Then, male C3H/HeJ mice were submitted to a diethylnitrosamine/carbon tetrachloride-induced model. Animals received CAF (50 mg/kg), CAF+TRI (50 and 25 mg/kg), CAF+CGA (50 and 25 mg/kg) or CAF+TRI+CGA (50, 25 and 25 mg/kg), intragastrically, 5×/week, for 10 weeks. Only CAF+TRI+CGA combination reduced the incidence, number and proliferation (Ki-67) of hepatocellular preneoplastic foci while enhanced apoptosis (cleaved caspase-3) in adjacent parenchyma. CAF+TRI+CGA treatment also decreased hepatic oxidative stress and enhanced the antioxidant Nrf2 axis. CAF+TRI+CGA had the most pronounced effects on decreasing hepatic pro-inflammatory IL-17 and NFκB, contributing to reduce CD68-positive macrophage number, stellate cell activation, and collagen deposition. In agreement, CAF+TRI+CGA upregulated tumor suppressors miR-144-3p, miR-376a-3p and antifibrotic miR-15b-5p, frequently deregulated in human HCC. CAF+TRI+CGA reduced the hepatic protein levels of pro-proliferative EGFR (miR-144-3p target), antiapoptotic Bcl-2 family members (miR-15b-5p targets), and the number of PCNA (miR-376a-3p target) positive hepatocytes in preneoplastic foci. Our results suggest that the combination of most common and highly bioavailable coffee compounds, rather than CAF individually, attenuates fibrosis-associated hepatocarcinogenesis by modulating miRNA expression profile.
publishDate 2020
dc.date.none.fl_str_mv 2020-12-12T02:22:06Z
2020-12-12T02:22:06Z
2020-11-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1016/j.jnutbio.2020.108479
Journal of Nutritional Biochemistry, v. 85.
1873-4847
0955-2863
http://hdl.handle.net/11449/201020
10.1016/j.jnutbio.2020.108479
2-s2.0-85090426256
url http://dx.doi.org/10.1016/j.jnutbio.2020.108479
http://hdl.handle.net/11449/201020
identifier_str_mv Journal of Nutritional Biochemistry, v. 85.
1873-4847
0955-2863
10.1016/j.jnutbio.2020.108479
2-s2.0-85090426256
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Journal of Nutritional Biochemistry
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv repositoriounesp@unesp.br
_version_ 1810021373627596800